nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—Angina pectoris—Liothyronine—hypothyroidism	0.0161	0.043	CcSEcCtD
Pseudoephedrine—NFATC1—heart—hypothyroidism	0.0157	0.0553	CbGeAlD
Pseudoephedrine—NFATC1—cardiovascular system—hypothyroidism	0.0148	0.0522	CbGeAlD
Pseudoephedrine—IL2—heart—hypothyroidism	0.0143	0.0506	CbGeAlD
Pseudoephedrine—IL2—cardiovascular system—hypothyroidism	0.0135	0.0477	CbGeAlD
Pseudoephedrine—Arrhythmia—Liothyronine—hypothyroidism	0.0118	0.0316	CcSEcCtD
Pseudoephedrine—NFATC1—adrenal gland—hypothyroidism	0.0117	0.0413	CbGeAlD
Pseudoephedrine—NFATC1—blood—hypothyroidism	0.0117	0.0413	CbGeAlD
Pseudoephedrine—NFATC1—thyroid gland—hypothyroidism	0.0113	0.0398	CbGeAlD
Pseudoephedrine—TNF—blood—hypothyroidism	0.0112	0.0394	CbGeAlD
Pseudoephedrine—NFATC1—female gonad—hypothyroidism	0.0109	0.0385	CbGeAlD
Pseudoephedrine—IL2—blood—hypothyroidism	0.0107	0.0377	CbGeAlD
Pseudoephedrine—IL2—thyroid gland—hypothyroidism	0.0103	0.0364	CbGeAlD
Pseudoephedrine—SLC6A3—nerve—hypothyroidism	0.0102	0.036	CbGeAlD
Pseudoephedrine—IL2—female gonad—hypothyroidism	0.00997	0.0352	CbGeAlD
Pseudoephedrine—Hypertension—Liothyronine—hypothyroidism	0.00993	0.0266	CcSEcCtD
Pseudoephedrine—NFATC1—testis—hypothyroidism	0.00967	0.0341	CbGeAlD
Pseudoephedrine—Tachycardia—Liothyronine—hypothyroidism	0.00916	0.0245	CcSEcCtD
Pseudoephedrine—Irritability—Dextrothyroxine—hypothyroidism	0.00895	0.024	CcSEcCtD
Pseudoephedrine—Irritability—Levothyroxine—hypothyroidism	0.00895	0.024	CcSEcCtD
Pseudoephedrine—NFATC1—cerebellum—hypothyroidism	0.00893	0.0315	CbGeAlD
Pseudoephedrine—Lightheadedness—Liotrix—hypothyroidism	0.0085	0.0228	CcSEcCtD
Pseudoephedrine—IL2—liver—hypothyroidism	0.00836	0.0295	CbGeAlD
Pseudoephedrine—SLC6A2—nerve—hypothyroidism	0.00823	0.029	CbGeAlD
Pseudoephedrine—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00789	0.0211	CcSEcCtD
Pseudoephedrine—Angina pectoris—Levothyroxine—hypothyroidism	0.00789	0.0211	CcSEcCtD
Pseudoephedrine—MAOA—nerve—hypothyroidism	0.00758	0.0268	CbGeAlD
Pseudoephedrine—Body temperature increased—Liothyronine—hypothyroidism	0.00742	0.0199	CcSEcCtD
Pseudoephedrine—Sweating—Levothyroxine—hypothyroidism	0.00693	0.0185	CcSEcCtD
Pseudoephedrine—Sweating—Dextrothyroxine—hypothyroidism	0.00693	0.0185	CcSEcCtD
Pseudoephedrine—Irritability—Liotrix—hypothyroidism	0.00658	0.0176	CcSEcCtD
Pseudoephedrine—CYP2D6—urine—hypothyroidism	0.00653	0.023	CbGeAlD
Pseudoephedrine—Angina pectoris—Liotrix—hypothyroidism	0.00581	0.0155	CcSEcCtD
Pseudoephedrine—Arrhythmia—Levothyroxine—hypothyroidism	0.0058	0.0155	CcSEcCtD
Pseudoephedrine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.0058	0.0155	CcSEcCtD
Pseudoephedrine—Tension—Dextrothyroxine—hypothyroidism	0.00554	0.0148	CcSEcCtD
Pseudoephedrine—Tension—Levothyroxine—hypothyroidism	0.00554	0.0148	CcSEcCtD
Pseudoephedrine—Nervousness—Dextrothyroxine—hypothyroidism	0.00548	0.0147	CcSEcCtD
Pseudoephedrine—Nervousness—Levothyroxine—hypothyroidism	0.00548	0.0147	CcSEcCtD
Pseudoephedrine—Tremor—Dextrothyroxine—hypothyroidism	0.00529	0.0142	CcSEcCtD
Pseudoephedrine—Tremor—Levothyroxine—hypothyroidism	0.00529	0.0142	CcSEcCtD
Pseudoephedrine—Agitation—Levothyroxine—hypothyroidism	0.00519	0.0139	CcSEcCtD
Pseudoephedrine—Agitation—Dextrothyroxine—hypothyroidism	0.00519	0.0139	CcSEcCtD
Pseudoephedrine—Sweating—Liotrix—hypothyroidism	0.0051	0.0136	CcSEcCtD
Pseudoephedrine—Palpitations—Dextrothyroxine—hypothyroidism	0.00499	0.0134	CcSEcCtD
Pseudoephedrine—Palpitations—Levothyroxine—hypothyroidism	0.00499	0.0134	CcSEcCtD
Pseudoephedrine—Anxiety—Levothyroxine—hypothyroidism	0.00479	0.0128	CcSEcCtD
Pseudoephedrine—Anxiety—Dextrothyroxine—hypothyroidism	0.00479	0.0128	CcSEcCtD
Pseudoephedrine—Confusional state—Dextrothyroxine—hypothyroidism	0.00465	0.0124	CcSEcCtD
Pseudoephedrine—Confusional state—Levothyroxine—hypothyroidism	0.00465	0.0124	CcSEcCtD
Pseudoephedrine—Tachycardia—Dextrothyroxine—hypothyroidism	0.0045	0.012	CcSEcCtD
Pseudoephedrine—Tachycardia—Levothyroxine—hypothyroidism	0.0045	0.012	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00446	0.0119	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00446	0.0119	CcSEcCtD
Pseudoephedrine—Arrhythmia—Liotrix—hypothyroidism	0.00426	0.0114	CcSEcCtD
Pseudoephedrine—Insomnia—Levothyroxine—hypothyroidism	0.00417	0.0112	CcSEcCtD
Pseudoephedrine—Insomnia—Dextrothyroxine—hypothyroidism	0.00417	0.0112	CcSEcCtD
Pseudoephedrine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00411	0.011	CcSEcCtD
Pseudoephedrine—Dyspnoea—Levothyroxine—hypothyroidism	0.00411	0.011	CcSEcCtD
Pseudoephedrine—Tension—Liotrix—hypothyroidism	0.00408	0.0109	CcSEcCtD
Pseudoephedrine—Nervousness—Liotrix—hypothyroidism	0.00403	0.0108	CcSEcCtD
Pseudoephedrine—Tremor—Liotrix—hypothyroidism	0.00389	0.0104	CcSEcCtD
Pseudoephedrine—Agitation—Liotrix—hypothyroidism	0.00382	0.0102	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Levothyroxine—hypothyroidism	0.0038	0.0102	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.0038	0.0102	CcSEcCtD
Pseudoephedrine—Palpitations—Liotrix—hypothyroidism	0.00367	0.00983	CcSEcCtD
Pseudoephedrine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00364	0.00975	CcSEcCtD
Pseudoephedrine—Body temperature increased—Levothyroxine—hypothyroidism	0.00364	0.00975	CcSEcCtD
Pseudoephedrine—ADRB1—heart—hypothyroidism	0.00359	0.0127	CbGeAlD
Pseudoephedrine—Hypertension—Liotrix—hypothyroidism	0.00359	0.0096	CcSEcCtD
Pseudoephedrine—Chest pain—Liotrix—hypothyroidism	0.00354	0.00947	CcSEcCtD
Pseudoephedrine—Anxiety—Liotrix—hypothyroidism	0.00352	0.00943	CcSEcCtD
Pseudoephedrine—Confusional state—Liotrix—hypothyroidism	0.00342	0.00915	CcSEcCtD
Pseudoephedrine—ADRB1—cardiovascular system—hypothyroidism	0.00339	0.012	CbGeAlD
Pseudoephedrine—Tachycardia—Liotrix—hypothyroidism	0.00331	0.00886	CcSEcCtD
Pseudoephedrine—Asthenia—Levothyroxine—hypothyroidism	0.00331	0.00885	CcSEcCtD
Pseudoephedrine—Asthenia—Dextrothyroxine—hypothyroidism	0.00331	0.00885	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Liotrix—hypothyroidism	0.00328	0.00877	CcSEcCtD
Pseudoephedrine—Anorexia—Liotrix—hypothyroidism	0.00323	0.00865	CcSEcCtD
Pseudoephedrine—Insomnia—Liotrix—hypothyroidism	0.00307	0.00821	CcSEcCtD
Pseudoephedrine—Dyspnoea—Liotrix—hypothyroidism	0.00302	0.00809	CcSEcCtD
Pseudoephedrine—Decreased appetite—Liotrix—hypothyroidism	0.00295	0.00789	CcSEcCtD
Pseudoephedrine—Vomiting—Levothyroxine—hypothyroidism	0.00293	0.00785	CcSEcCtD
Pseudoephedrine—Vomiting—Dextrothyroxine—hypothyroidism	0.00293	0.00785	CcSEcCtD
Pseudoephedrine—MAOA—adrenal cortex—hypothyroidism	0.00291	0.0103	CbGeAlD
Pseudoephedrine—Rash—Dextrothyroxine—hypothyroidism	0.00291	0.00778	CcSEcCtD
Pseudoephedrine—Rash—Levothyroxine—hypothyroidism	0.00291	0.00778	CcSEcCtD
Pseudoephedrine—Dermatitis—Dextrothyroxine—hypothyroidism	0.0029	0.00777	CcSEcCtD
Pseudoephedrine—Dermatitis—Levothyroxine—hypothyroidism	0.0029	0.00777	CcSEcCtD
Pseudoephedrine—Headache—Dextrothyroxine—hypothyroidism	0.00289	0.00773	CcSEcCtD
Pseudoephedrine—Headache—Levothyroxine—hypothyroidism	0.00289	0.00773	CcSEcCtD
Pseudoephedrine—ADRA1A—heart—hypothyroidism	0.00284	0.01	CbGeAlD
Pseudoephedrine—MAOA—heart—hypothyroidism	0.00281	0.00993	CbGeAlD
Pseudoephedrine—Feeling abnormal—Liotrix—hypothyroidism	0.00279	0.00748	CcSEcCtD
Pseudoephedrine—Nausea—Dextrothyroxine—hypothyroidism	0.00274	0.00733	CcSEcCtD
Pseudoephedrine—Nausea—Levothyroxine—hypothyroidism	0.00274	0.00733	CcSEcCtD
Pseudoephedrine—Body temperature increased—Liotrix—hypothyroidism	0.00268	0.00717	CcSEcCtD
Pseudoephedrine—ADRA1A—cardiovascular system—hypothyroidism	0.00268	0.00946	CbGeAlD
Pseudoephedrine—MAOA—cardiovascular system—hypothyroidism	0.00266	0.00937	CbGeAlD
Pseudoephedrine—SLC6A2—gonad—hypothyroidism	0.00262	0.00923	CbGeAlD
Pseudoephedrine—SLC6A4—blood—hypothyroidism	0.00259	0.00914	CbGeAlD
Pseudoephedrine—Asthenia—Liotrix—hypothyroidism	0.00243	0.00651	CcSEcCtD
Pseudoephedrine—MAOA—pituitary gland—hypothyroidism	0.00235	0.0083	CbGeAlD
Pseudoephedrine—SLC6A3—testis—hypothyroidism	0.00234	0.00825	CbGeAlD
Pseudoephedrine—SLC6A2—adrenal gland—hypothyroidism	0.00228	0.00805	CbGeAlD
Pseudoephedrine—Dizziness—Liotrix—hypothyroidism	0.00224	0.006	CcSEcCtD
Pseudoephedrine—ADRA2A—heart—hypothyroidism	0.00216	0.00762	CbGeAlD
Pseudoephedrine—SLC6A3—cerebellum—hypothyroidism	0.00216	0.00762	CbGeAlD
Pseudoephedrine—Vomiting—Liotrix—hypothyroidism	0.00216	0.00577	CcSEcCtD
Pseudoephedrine—Rash—Liotrix—hypothyroidism	0.00214	0.00572	CcSEcCtD
Pseudoephedrine—Dermatitis—Liotrix—hypothyroidism	0.00214	0.00572	CcSEcCtD
Pseudoephedrine—Headache—Liotrix—hypothyroidism	0.00212	0.00569	CcSEcCtD
Pseudoephedrine—ADRA1A—adrenal gland—hypothyroidism	0.00212	0.00748	CbGeAlD
Pseudoephedrine—ADRA1A—blood—hypothyroidism	0.00212	0.00748	CbGeAlD
Pseudoephedrine—MAOA—adrenal gland—hypothyroidism	0.0021	0.00741	CbGeAlD
Pseudoephedrine—MAOA—blood—hypothyroidism	0.0021	0.00741	CbGeAlD
Pseudoephedrine—MAOA—thyroid gland—hypothyroidism	0.00203	0.00715	CbGeAlD
Pseudoephedrine—Nausea—Liotrix—hypothyroidism	0.00201	0.00539	CcSEcCtD
Pseudoephedrine—MAOA—female gonad—hypothyroidism	0.00196	0.00691	CbGeAlD
Pseudoephedrine—SLC6A2—testis—hypothyroidism	0.00189	0.00665	CbGeAlD
Pseudoephedrine—ADRA2A—gonad—hypothyroidism	0.00185	0.00653	CbGeAlD
Pseudoephedrine—ADRA2A—pituitary gland—hypothyroidism	0.0018	0.00637	CbGeAlD
Pseudoephedrine—MAOA—testis—hypothyroidism	0.00174	0.00613	CbGeAlD
Pseudoephedrine—ADRA1A—liver—hypothyroidism	0.00166	0.00585	CbGeAlD
Pseudoephedrine—MAOA—liver—hypothyroidism	0.00164	0.0058	CbGeAlD
Pseudoephedrine—ADRA1A—cerebellum—hypothyroidism	0.00162	0.00571	CbGeAlD
Pseudoephedrine—ADRA2A—adrenal gland—hypothyroidism	0.00161	0.00569	CbGeAlD
Pseudoephedrine—ADRA2A—blood—hypothyroidism	0.00161	0.00569	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—hypothyroidism	0.0016	0.00566	CbGeAlD
Pseudoephedrine—ADRA2A—thyroid gland—hypothyroidism	0.00156	0.00549	CbGeAlD
Pseudoephedrine—ADRA2A—female gonad—hypothyroidism	0.0015	0.0053	CbGeAlD
Pseudoephedrine—ADRA2A—testis—hypothyroidism	0.00133	0.0047	CbGeAlD
Pseudoephedrine—CYP2D6—blood—hypothyroidism	0.00125	0.0044	CbGeAlD
Pseudoephedrine—ADRA2A—cerebellum—hypothyroidism	0.00123	0.00434	CbGeAlD
Pseudoephedrine—CYP2D6—female gonad—hypothyroidism	0.00116	0.00411	CbGeAlD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00105	0.00307	CbGpPWpGaD
Pseudoephedrine—ADRB1—G alpha (s) signalling events—TSHB—hypothyroidism	0.00104	0.00303	CbGpPWpGaD
Pseudoephedrine—ADRB1—G alpha (s) signalling events—TSHR—hypothyroidism	0.00104	0.00303	CbGpPWpGaD
Pseudoephedrine—CYP2D6—testis—hypothyroidism	0.00103	0.00364	CbGeAlD
Pseudoephedrine—ADRB2—G alpha (s) signalling events—TSHB—hypothyroidism	0.00102	0.00296	CbGpPWpGaD
Pseudoephedrine—ADRB2—G alpha (s) signalling events—TSHR—hypothyroidism	0.00102	0.00296	CbGpPWpGaD
Pseudoephedrine—TNF—Ceramide signaling pathway—IGF1—hypothyroidism	0.000991	0.00289	CbGpPWpGaD
Pseudoephedrine—CYP2D6—liver—hypothyroidism	0.000976	0.00344	CbGeAlD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000962	0.0028	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—SH2B3—hypothyroidism	0.000958	0.00279	CbGpPWpGaD
Pseudoephedrine—CYP2D6—cerebellum—hypothyroidism	0.000953	0.00336	CbGeAlD
Pseudoephedrine—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.000936	0.00273	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000932	0.00272	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000894	0.00261	CbGpPWpGaD
Pseudoephedrine—TNF—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000889	0.00259	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CLTC—hypothyroidism	0.000865	0.00252	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000805	0.00235	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000785	0.00229	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (12/13) signalling events—VAV3—hypothyroidism	0.000768	0.00224	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—TRH—hypothyroidism	0.000762	0.00222	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—NEFL—hypothyroidism	0.000737	0.00215	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CLTC—hypothyroidism	0.000731	0.00213	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000713	0.00208	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—VAV3—hypothyroidism	0.0007	0.00204	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000699	0.00204	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TRH—hypothyroidism	0.000692	0.00202	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.000685	0.002	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—TSHR—hypothyroidism	0.000679	0.00198	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—TSHB—hypothyroidism	0.000679	0.00198	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—TRH—hypothyroidism	0.000679	0.00198	CbGpPWpGaD
Pseudoephedrine—MAOA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000663	0.00193	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—VAV3—hypothyroidism	0.000657	0.00192	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000645	0.00188	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—IGF1—hypothyroidism	0.000633	0.00185	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000633	0.00185	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TSHB—hypothyroidism	0.000617	0.0018	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TSHR—hypothyroidism	0.000617	0.0018	CbGpPWpGaD
Pseudoephedrine—ADRB1—G alpha (s) signalling events—AVP—hypothyroidism	0.000612	0.00178	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000607	0.00177	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000604	0.00176	CbGpPWpGaD
Pseudoephedrine—ADRB2—G alpha (s) signalling events—AVP—hypothyroidism	0.000599	0.00174	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000573	0.00167	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000572	0.00167	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000571	0.00166	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CLTC—hypothyroidism	0.000559	0.00163	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000555	0.00162	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000543	0.00158	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000535	0.00156	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CLTC—hypothyroidism	0.000529	0.00154	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000507	0.00148	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000495	0.00144	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000495	0.00144	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000484	0.00141	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000484	0.00141	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TRH—hypothyroidism	0.000483	0.00141	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000474	0.00138	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CLTC—hypothyroidism	0.000473	0.00138	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00045	0.00131	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000449	0.00131	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IGF1—hypothyroidism	0.000447	0.0013	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—PRL—hypothyroidism	0.00044	0.00128	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TSHB—hypothyroidism	0.000431	0.00126	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TSHR—hypothyroidism	0.000431	0.00126	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TRH—hypothyroidism	0.000423	0.00123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000418	0.00122	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—IYD—hypothyroidism	0.000416	0.00121	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—VAV3—hypothyroidism	0.000415	0.00121	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TRH—hypothyroidism	0.000414	0.00121	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TRH—hypothyroidism	0.000409	0.00119	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—VAV3—hypothyroidism	0.000407	0.00119	CbGpPWpGaD
Pseudoephedrine—ADRB1—G alpha (s) signalling events—POMC—hypothyroidism	0.000407	0.00119	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PRL—hypothyroidism	0.000407	0.00119	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—IGF1—hypothyroidism	0.000405	0.00118	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000401	0.00117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000401	0.00117	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AVP—hypothyroidism	0.0004	0.00117	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.0004	0.00116	CbGpPWpGaD
Pseudoephedrine—ADRB2—G alpha (s) signalling events—POMC—hypothyroidism	0.000398	0.00116	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SH2B3—hypothyroidism	0.000384	0.00112	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—VAV3—hypothyroidism	0.000377	0.0011	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TSHB—hypothyroidism	0.000377	0.0011	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TSHR—hypothyroidism	0.000377	0.0011	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—PRL—hypothyroidism	0.000372	0.00109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000372	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000372	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TSHB—hypothyroidism	0.000369	0.00107	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TSHR—hypothyroidism	0.000369	0.00107	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TSHB—hypothyroidism	0.000364	0.00106	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TSHR—hypothyroidism	0.000364	0.00106	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AVP—hypothyroidism	0.000363	0.00106	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—AVP—hypothyroidism	0.000356	0.00104	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000356	0.00104	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000354	0.00103	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ATP5O—hypothyroidism	0.000353	0.00103	CbGpPWpGaD
Pseudoephedrine—MAOA—Biological oxidations—POMC—hypothyroidism	0.000352	0.00103	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—VAV3—hypothyroidism	0.000345	0.001	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TRH—hypothyroidism	0.000342	0.000997	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TPO—hypothyroidism	0.000332	0.000968	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000328	0.000957	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SH2B3—hypothyroidism	0.000325	0.000946	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000319	0.000929	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TRH—hypothyroidism	0.000318	0.000927	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TSHB—hypothyroidism	0.000305	0.000889	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TSHR—hypothyroidism	0.000305	0.000889	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000301	0.000877	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000292	0.00085	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000289	0.000841	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000285	0.000832	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PRL—hypothyroidism	0.000285	0.00083	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TSHB—hypothyroidism	0.000283	0.000826	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TSHR—hypothyroidism	0.000283	0.000826	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—IYD—hypothyroidism	0.000278	0.000809	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—POMC—hypothyroidism	0.000266	0.000775	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VAV3—hypothyroidism	0.000263	0.000768	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000258	0.000752	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AVP—hypothyroidism	0.000254	0.00074	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VAV3—hypothyroidism	0.000249	0.000726	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—POMC—hypothyroidism	0.000241	0.000704	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PRL—hypothyroidism	0.000241	0.000702	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TRH—hypothyroidism	0.000239	0.000697	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000236	0.000688	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ATP5O—hypothyroidism	0.000236	0.000688	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TRH—hypothyroidism	0.000234	0.000681	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000228	0.000666	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SH2B3—hypothyroidism	0.000226	0.000658	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VAV3—hypothyroidism	0.000223	0.000649	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—AVP—hypothyroidism	0.000222	0.000648	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TPO—hypothyroidism	0.000222	0.000647	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000219	0.000639	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—AVP—hypothyroidism	0.000217	0.000633	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TRH—hypothyroidism	0.000217	0.000633	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AVP—hypothyroidism	0.000215	0.000626	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TSHB—hypothyroidism	0.000213	0.000621	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TSHR—hypothyroidism	0.000213	0.000621	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TRH—hypothyroidism	0.000212	0.000619	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TSHB—hypothyroidism	0.000208	0.000607	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TSHR—hypothyroidism	0.000208	0.000607	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000203	0.000592	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000194	0.000565	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TSHB—hypothyroidism	0.000193	0.000564	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TSHR—hypothyroidism	0.000193	0.000564	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	0.000193	0.000564	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00019	0.000553	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TSHR—hypothyroidism	0.000189	0.000552	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TSHB—hypothyroidism	0.000189	0.000552	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000185	0.00054	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	0.000183	0.000534	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—IYD—hypothyroidism	0.000181	0.000527	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00018	0.000524	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	0.00018	0.000524	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	0.00018	0.000524	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	0.000176	0.000512	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000172	0.000502	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000172	0.000502	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—POMC—hypothyroidism	0.000169	0.000492	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	0.000167	0.000487	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	0.000163	0.000476	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IGF1—hypothyroidism	0.000162	0.000473	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	0.00016	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	0.00016	0.000467	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000157	0.000457	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	0.000157	0.000456	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	0.000157	0.000456	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VAV3—hypothyroidism	0.000155	0.000452	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000154	0.000448	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TSHB—hypothyroidism	0.000154	0.000448	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000153	0.000447	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CLTC—hypothyroidism	0.000148	0.000432	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—POMC—hypothyroidism	0.000148	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000146	0.000425	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	0.000145	0.000424	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	0.000145	0.000424	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CLTC—hypothyroidism	0.000145	0.000423	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPO—hypothyroidism	0.000145	0.000421	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—POMC—hypothyroidism	0.000144	0.000421	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—POMC—hypothyroidism	0.000143	0.000416	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IGF1—hypothyroidism	0.000137	0.0004	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3C2A—hypothyroidism	0.000137	0.000399	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—VAV3—hypothyroidism	0.00013	0.00038	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TRH—hypothyroidism	0.000128	0.000374	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—VAV3—hypothyroidism	0.000127	0.000372	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AVP—hypothyroidism	0.000126	0.000366	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TRH—hypothyroidism	0.000125	0.000366	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AVP—hypothyroidism	0.000123	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	0.00012	0.00035	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	0.000119	0.000348	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—VAV3—hypothyroidism	0.000118	0.000345	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—VAV3—hypothyroidism	0.000116	0.000337	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC5A5—hypothyroidism	0.000115	0.000336	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TSHB—hypothyroidism	0.000114	0.000333	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TSHR—hypothyroidism	0.000114	0.000333	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AVP—hypothyroidism	0.000114	0.000332	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TSHB—hypothyroidism	0.000112	0.000326	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TSHR—hypothyroidism	0.000112	0.000326	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AVP—hypothyroidism	0.000112	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	0.000112	0.000325	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	0.000111	0.000323	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000105	0.000307	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TRH—hypothyroidism	0.000104	0.000302	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TSHB—hypothyroidism	0.000103	0.000299	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SH2B3—hypothyroidism	0.000102	0.000297	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	0.000102	0.000296	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SH2B3—hypothyroidism	9.96e-05	0.00029	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	9.8e-05	0.000286	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TRH—hypothyroidism	9.64e-05	0.000281	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	9.58e-05	0.000279	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IGF1—hypothyroidism	9.55e-05	0.000278	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	9.44e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	9.25e-05	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	9.25e-05	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	9.23e-05	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	9.16e-05	0.000267	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	8.9e-05	0.000259	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	8.59e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	8.59e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	8.57e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—POMC—hypothyroidism	8.34e-05	0.000243	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	8.24e-05	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—POMC—hypothyroidism	8.16e-05	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC5A5—hypothyroidism	7.69e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	7.66e-05	0.000223	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—POMC—hypothyroidism	7.58e-05	0.000221	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRL—hypothyroidism	7.56e-05	0.00022	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—POMC—hypothyroidism	7.41e-05	0.000216	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRL—hypothyroidism	7.39e-05	0.000215	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VAV3—hypothyroidism	6.99e-05	0.000204	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VAV3—hypothyroidism	6.84e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	6.75e-05	0.000197	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AVP—hypothyroidism	6.74e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TSHB—hypothyroidism	6.7e-05	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AVP—hypothyroidism	6.59e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	6.27e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	6.13e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRL—hypothyroidism	6.11e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—POMC—hypothyroidism	6.02e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	5.97e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	5.7e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRL—hypothyroidism	5.68e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	5.66e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AVP—hypothyroidism	5.45e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	5.26e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AVP—hypothyroidism	5.06e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	5.01e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—POMC—hypothyroidism	4.48e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—POMC—hypothyroidism	4.38e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—hypothyroidism	4.31e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—hypothyroidism	4.21e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—POMC—hypothyroidism	4.02e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—POMC—hypothyroidism	3.62e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	3.48e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—POMC—hypothyroidism	3.36e-05	9.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	3.24e-05	9.43e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—POMC—hypothyroidism	2.62e-05	7.64e-05	CbGpPWpGaD
